Journal of Bone and Mineral Research · 2011 · 85 citations · 16 references
MedicineGeneticsMolecular GeneticsBone MetabolismHuman GeneticsMedical GeneticsBone DevelopmentBone DisordersBone PathologyConnective Tissue DisordersOsteogenesisOsteogenesis ImperfectaCol1a2 MutationsCollagen Type I SynthesisFrameshift MutationsHeritable Connective Tissue DisordersLong Bone DeformitiesLow Bone MassOsteogenesis Imperfecta GeneticsPigment Epithelium-derived Factor
Osteogenesis imperfecta (OI) is a clinically heterogeneous heritable connective tissue disorder, characterized by low bone mass and reduced strength, which result in susceptibility to fracture and bone deformities. In most cases it is caused by dominant mutations in type I collagen genes, COL1A1 and COL1A2. Recessive forms, which collectively account for approximately 5% of cases of osteogenesis imperfecta detected in North America and Europe, are caused instead by mutations in various genes coding for proteins involved in collagen posttranslational modifications, folding, and secretion. A novel disease locus, SERPINF1, coding for pigment epithelium-derived factor (PEDF), has been found recently. In SERPINF1 mutants described so far, synthesis, posttranslational modification, and secretion of type I collagen were reported to be normal. Here we describe three siblings born to consanguineous parents, who show an initially mild and then progressively worsening form of OI with severe deformities of the long bones. They are homozygous for a frameshift mutation in exon 4 of the SERPINF1 gene, which leads to lack of the transcription/translation product, likely a key factor in bone deposition and remodeling. Synthesis and secretion of type I collagen are normal. Clinical, radiographic, histological, and histomorphometric data from the proband are reminiscent of the distinctive features of type VI OI.
16
Genetic heterogeneity in osteogenesis imperfecta.
David Sillence, A Senn, D. M. Danks · Journal of Medical Genetics · 1979 · 2.2K citations · Full text
Medicine, Genetics, Bone Metabolism +16
CRTAP Is Required for Prolyl 3- Hydroxylation and Mutations Cause Recessive Osteogenesis Imperfecta
Roy Morello, Terry Bertin, Yuqing Chen et al. · Cell · 2006 · 530 citations · Full text